BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1363485)

  • 1. A simple biological way to screen dopaminergic agonists.
    de Azeredo FA; Ribeiro MF
    Metab Brain Dis; 1992 Dec; 7(4):211-21. PubMed ID: 1363485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
    Borowsky B; Kuhn CM
    Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
    Moody CA; Robinson SR; Spear LP; Smotherman WP
    Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 and D2 receptors and circling behavior in rats with unilateral lesion of the entopeduncular nucleus.
    Pazo JH; Murer GM; Segal E
    Brain Res Bull; 1993; 30(5-6):635-9. PubMed ID: 8096164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors.
    Castellano C; Cestari V; Cabib S; Puglisi-Allegra S
    Behav Neural Biol; 1994 Mar; 61(2):156-61. PubMed ID: 7911301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset.
    Elliott PJ; Walsh DM; Close SP
    Neurosci Lett; 1992 Aug; 142(1):1-4. PubMed ID: 1357609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.